"We would encourage you to visit www.coronavirus.gov for the latest information and guidance related to COVID-19"
Pre-Registration closes on: May 26, 2023
Get your pass now until price go up & save 40%
Stanley A. Plotkin, Ph.D.
Consultant and Emeritus Professor of the University of Pennsylvania, Vaxconsult, LLPPresentation Title
Rino Rappuoli, Ph.D.
Scientific Director, Biotecnopolo di Siena Foundation, Italy
Andrew J Pollard, FMedSci
Ashall Professor of Paediatric Infection and Immunity and Director of Oxford Vaccine Group
Paul Burton, MD Ph.D. FACC MRCS
Chief Medical Officer, Moderna
Walter Straus, MD, MPH, FACP
Vice-President, Clinical Safety, Moderna
President, Global Immunization, Sabin Vaccine Institute
Jay A. Berzofsky, MD.,Ph.D
Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute
Alessandro Sette, Dr.Biol.Sci.
Professor, Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research, La Jolla Institute for ImmunologyPresentation Title
Ofer Levy, MD, PhD
Staff Physician & Principal Investigator, Director, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital Professor, Harvard Medical School
Hanneke Schuitemaker, PhD
VP, Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines and Prevention B.V.
Karin Bok, MS, PhD
Acting Deputy Director, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Mary Marovich, MD, FACP, DTMH
NIH, NIAID, Division of AIDS, Director, Vaccine Research Program
Swati Gupta, DrPH, MPH
VP, Emerging Infectious Diseases and Epidemiology, IAVI
Dan Barouch, M.D., Ph.D.
William Bosworth Castle Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT, and Harvard, Director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
David B. Weiner, Ph.D.
Executive Vice President, The Wistar Institute, Director, Vaccine & Immunotherapy Center
Kate Broderick, Ph.D.
Chief Innovation Officer, Maravai LifeSciences
Gary Kobinger, PhD, OM, MSC
Director, Galveston National Laboratory
Saad B. Omer, MBBS MPH Ph.D. FIDSA
Director, Yale Institute for Global Health
Francesco Berlanda Scorza, Ph.D.
VP, Global Health R&D Vaccines Head and GVGH Institute Director, GSK Vaccines Institute for Global Health
Richard B. Kennedy, Ph.D.
Professor of Medicine, Co-Director, Mayo Clinic Vaccine Research GroupPresentation Title
Marco Pravetoni, Ph.D.
Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Director, Center for Medication Development for Substance Use Disorders and Overdose
Barbara A Jones, Ph.D.
IBM Quantum, IBM Research Almaden
Alexander Bukreyev, Ph.D.
Professor, Co-Principal Investigator Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus, Departments of Pathology and Microbiology & Immunology, Galveston National Laboratory, University of Texas Medical Branch
Farshad Guirakhoo, Ph.D.
Chief Scientific Officer, ExpreS2ion Biotechnologies
Stephen L. Hoffman, M.D.
Chief Executive and Scientific Officer, Sanaria Inc.
Rama Rao Amara, Ph.D.
Charles Howard Candler Professor, Department of Microbiology and Immunology, Associate Director, Vaccine Development, Emory Vaccine Center, Co-Director, Developmental Core, Emory CFAR, Emory National Primate Research Center, Emory University
Robert O. Dillman, M.D.
Chief Medical Officer, AIVITA Biomedical, Inc., Clinical Professor of Medicine, UC Irvine
Magdalena Tary-Lehmann, M.D., Ph.D.
Chief Scientific Officer, Cellular Technology Limited, Adjunct Associate Professor of Pathology, Case Western Reserve University
John Shon, MD, MS
Chief Technology Officer, Serimmune
Shahin Gharakhanian, MD, DPH
Pharmaceutical Medicine, Infectious Diseases, Member, IDSA: Infectious Diseases Society of America. Shahin Gharakhanian MD Consulting LLC
Biao He, Ph.D.
President & CEO, CyanVac LLC
Christopher Rudd, PhD, DSc, FRSC
Professeur, Faculte de Medicine, Dept de microbiologie, infectiologie et immunologie, Director-Cell Signaling and Immunotherapy Section, Centre de Recherche Hopital Maisonneuve-Rosemont
Sriram Sathy, Ph.D.
Chief Scientific Officer, Codiak
Jonathan Lovell, Ph.D.
SUNY Empire Innovation Associate Professor, Department of Biomedical Engineering, Jacobs School of Medicine & Biomedical Sciences, University of Buffalo
Mark Connors, M.D.
Chief, HIV-Specific Immunity Section, NIAID/LIR
Jorge C. Blanco, Ph.D.
President and Scientific Director, Sigmovir Biosystems Inc.
Trudy Morrison, Ph.D.
University of Massachusetts Chan Medical School
Vaithilingaraja Arumugaswami, Ph.D.
Adjunct Associate Professor Molecular and Medical Pharmacology, University of California Los Angeles
Pi-Hui Liang, Ph.D.
Janet K. Yamamoto, Ph.D.
Professor and Director of VAB BSL-3 V3-213D Laboratory & LCIV-CA, Dept of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, University of Florida
SIDDAPPA N. BYRAREDDY, Ph.D.
Professor & Vice Chair of Research, Department of Pharmacology & Experimental Neuroscience, The University of Nebraska Medical Center
Tian (Tina) Wang, Ph.D.
Professor, Departments of Microbiology & Immunology and Pathology, Director, NIAID T35 Infectious Diseases & Inflammatory Disorder Training Program, Member, Sealy Institute for Vaccine Sciences
Daniel Kulp, Ph.D.
Associate Professor, Vaccine & Immunotherapy Center, The Wistar Institute
Marcus Buggert, Ph.D.
Assistant Professor, Karolinska Institutet
Martha A. Alexander-Miller, Ph.D.
Dolores G. Evans Ph.D. Chair in Microbiology and Immunology, Professor and Chair, Dept. of Microbiology and Immunology, Director Center for Vaccines at the Extremes of Aging, Wake Forest School of Medicine
Sukrit Srivastava, Ph.D.
Center for Structural Systems Biology (CSSB) & Indian Foundation for Fundamental Research Trust
Gongyi Zhang, Ph.D.
Professor, Department of Immunology and Genomic Medicine, National Jewish Health, Founder, NB Life Laboratory, LLC, Colorado, USA
Yuri L. Lyubchenko, PhD, DSc, Professor
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical CenterPresentation Title
Andrew Lees, Ph.D.
CEO/CSO, Fina Biosolutions
Gary R. Matyas, Ph.D.
Chief, Adjuvants and Formulation Section, Laboratory of Adjuvant and Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research
Oretta Finco, Ph.D.
Head of B Cell Center of Excellence (CoE) and Head of IT-Immunology, GSK (Bacterial Vaccines Unit)
Gavin Painter, Ph.D.
Victoria University Wellington
Niraj H. Tolia, Ph.D.
Senior Investigator, Chief, Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, Division of Intramural Research, NIAID/NIH
Jörg Hermann Fritz, Ph.D
Director, McGill Research Center on Complex Traits (MRCCT), Associate Professor, McGill University
Sebastian L Johnston, MBBS Ph.D
Professor of Respiratory Medicine & Allergy, Head, Airway Disease, National Heart and Lung Institute, Imperial College London
Edward T. Ryan, M.D., DTM&H
Director, Global Infectious Diseases; Division of Infectious Diseases, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School, Professor of Immunology & Infectious Diseases, Harvard T.H. Chan School of Public Health
Roberto Adamo, Ph.D
Vaccine Development Leader, GSK
De-chu Christopher Tang, Ph.D
CEO; VaxDome Inc., Commercialization Program, University of North Texas Health Science Center
Jolieke G. van Oosterwijk, PhD, MSc
Chief Scientific Officer, US BIOLOGIC
Wei Zou, PhD
Senior Research Officer, Human Health Therapeutic Research Center, National Research Council of Canada
Mehul S. Suthar, PhD
Associate Professor, Department of Pediatrics-Infectious Disease, Emory University School of Medicine
Xingmin Sun, PhD
Associate Professor, Department of Molecular Medicine, College of Medicine at the University of South Florida (USF).
Mark A. Emalfarb, PhD
CEO, Dyadic International, Inc.
Ruben Rizzi, MD
Vice President of Global Regulatory Affairs, BioNTech
Robert van der Put, MSc
Director Business Development, Scientist Process Development Conjugate Vaccines, Intravacc.nl
Cofounder and CEO, MBF Therapeutics
Jerald Sadoff, PhD
Senior Advisor Development, ID&V Therapeutic Area for Janssen R&D US, Johnson & Johnson
Patricia Martin, PhD
Managing Director & Vice President Clinical and Regulatory Affairs, LimmaTech Biologics AG
Nash Rochman, PhD
Principal Investigator, National Institutes of Health
Ulo Palm, MD, Ph.D., MBA
Chief Medical Office, Vaxxinity
M. Javad Aman, Ph.D.
President and CEO, AbVacc, Inc
Alexander Rumyantsev, MD, Ph.D., MBA
Therapeutic Area Head, Infectious Diseases, Vaxxinity
Ali Azizi, Ph.D.
Project Lead, CEPI
Byron Brook, Ph.D.
Research Fellow, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Harvard Institutes of Medicine
Stephen J. Elledge, Ph.D.
Department of Genetics, Harvard Medical School
Ling CHEN, M.D.,Ph.D.
Guangzhou Laboratory, Guangzhou, China
Afzal A. Siddiqui, M.Phil., Ph.D.
Grover E. Murray Professor, Chair, Immunology & Molecular Microbiology, Texas Tech University Health Sciences Center
Peter Nara, Ph.D.
Co-Founders, Chief Scientific Officer, and President of Business Development for Keystone Bio Inc.
Hangwen Li, Ph.D.
Founder, Chairman, and CEO, Stemirna Therapeutics Co., Ltd.